HemoType

Gurugram, India Founded: 2016 • Age: 10 yrs
Sickle cell disease diagnostic testing and screening services.

About HemoType

HemoType is a Healthcare company based in Gurugram (India) founded in 2016. Sickle cell disease diagnostic testing and screening services. HemoType offers products and services including HemoTypeSC Test and Dried Blood Spot Screening. Its focus areas include Health and Medical, Biotechnology, Immunoassays and Lateral Flow Tests. Its legal entity in India is CAREABILITY HEALTHCARE LLP (AAT-6320).

Company details

HemoTypeSC is recognized as a rapid diagnostic test for sickle cell disease, having been evaluated in numerous field studies across Africa, India, and other regions. It is noted for its high accuracy in detecting various hemoglobin phenotypes, with approvals and registrations in multiple countries. The tests affordability and ease of use are highlighted in publications and news articles, where it is described as a tool that addresses screening challenges in low-resource settings. Its ability to screen newborns and adults is supported by independent validations involving thousands of patients.

Products & Services of HemoType

HemoType offers a comprehensive portfolio of products and services, including HemoTypeSC Test and Dried Blood Spot Screening.

HemoTypeSC Test
Diagnostic Kits

Sickle cell disease screening is performed using a lateral flow immunoassay for rapid detection of specific hemoglobins

Dried Blood Spot Screening
Testing Services

Screening of dried blood spots is conducted for sickle cell disease detection in addition to fresh blood samples

Board of directors of Careability Healthcare Llp (HemoType)

Careability Healthcare Llp is the primary company behind HemoType. The board of Careability Healthcare Llp currently have 3 directors; the longest-serving is Kamal Kumar Gupta, appointed in 2020.

DirectorDesignationAppointedTenureEntity
Kamal Kumar Gupta
DIN 08859311
Designated Partner02 Sep 20206 yrs 2 moCareability Healthcare Llp
Shashi Bose
DIN 08859312
Designated Partner02 Sep 20206 yrs 2 moCareability Healthcare Llp
Ruchika Verma
DIN 08853427
Designated Partner02 Sep 20206 yrs 2 moCareability Healthcare Llp
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about HemoType

HemoType was founded in 2016.

HemoType is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

HemoTypeSC is recognized as a rapid diagnostic test for sickle cell disease, having been evaluated in numerous field studies across Africa, India, and other regions. It is noted for its high accuracy in detecting various hemoglobin phenotypes, with approvals and registrations in multiple countries. The tests affordability and ease of use are highlighted in publications and news articles, where it is described as a tool that addresses screening challenges in low-resource settings. Its ability to screen newborns and adults is supported by independent validations involving thousands of patients.

HemoType offers HemoTypeSC Test and Dried Blood Spot Screening.

HemoType operates through Careability Healthcare Llp.

The legal entities of HemoType currently have 3 directors, including Kamal Kumar Gupta, Shashi Bose, Ruchika Verma.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available